Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery

Journal of Cataract and Refractive Surgery

Volumn 31, Issue 9, 2005, Pages 1707-1712

  Chen, Teresa C ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; BRIMONIDINE;

ADULT; AGED; ANTERIOR EYE SEGMENT; ARGON LASER; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CAPSULOTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HEART RATE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIDOTOMY; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TRABECULOPLASTY;

ADRENERGIC ALPHA-AGONISTS; AGED; ANTERIOR EYE SEGMENT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLONIDINE; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; IRIDECTOMY; LASER SURGERY; LENS CAPSULE, CRYSTALLINE; MALE; OCULAR HYPERTENSION; POSTOPERATIVE COMPLICATIONS; QUINOXALINES; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 27144551958     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2005.02.035     Document Type: Article

References (38)

1. T. Krupin, A.E. Kolker, M.A. Kass, and B. Becker Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma Ophthalmology 91 1984 361 365 discussion by D Minckler, 365
2. R.N. Weinreb, J. Ruderman, R. Juster, and K. Zweig Immediate intraocular pressure response to argon laser trabeculoplasty Am J Ophthalmol 95 1983 279 286
3. A.L. Robin, I.P. Pollack, B. House, and C. Enger Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty Arch Ophthalmol 105 1987 646 650
4. H.S. Chung, D.H. Shin, and C.M. Birt Chronic use of apraclonidine decreases its moderation of postlaser intraocular pressure spikes Ophthalmology 104 1997 1921 1925
5. H.D. Hoskins Jr., J. Hetherington Jr., and D.S. Minckler Complications of laser trabeculoplasty Ophthalmology 90 1983 796 799
6. M.J. Flohr, A.L. Robin, and J.S. Kelley Early complications following Q-switched neodymium:YAG laser posterior capsulotomy Ophthalmology 92 1985 360 363
7. S.V.L. Brown, J.V. Thomas, C.D. Belcher III, and R.J. Simmons Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium:YAG posterior capsulotomy Ophthalmology 92 1985 354 359
8. M.M. Channell, and H. Beckmann Intraocular pressure changes after neodymium-YAG laser posterior capsulotomy Arch Ophthalmol 102 1984 1024 1026
9. R.D. Cullom Jr., and L.W. Schwartz The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy Ophthalmic Surg 24 1993 623 626
10. I.P. Pollack, R.H. Brown, and A.S. Crandall Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy Trans Am Ophthalmol Soc 86 1988 461 469 discussion 469-472
11. D.E. Silverstone, S.F. Brint, and K.W. Olander Prophylactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies Am J Ophthalmol 113 1992 401 405
12. A.L. Robin, and I.P. Pollack A comparison of neodymium:YAG and argon laser iridotomies Ophthalmology 91 1984 1011 1016
13. T. Krupin, R.A. Stone, and B.H. Cohen Acute intraocular pressure response to argon laser iridotomy Ophthalmology 92 1985 922 925 discussion by IP Pollack, 925-926
14. Y. Kitazawa, T. Taniguchi, and K. Sugiyama Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy Ophthalmic Surg 20 1989 49 52
15. C. Hong, K.Y. Song, W.H. Park, and Y.H. Sohn Effect of apraclonidine hydrochloride on acute intraocular pressure rise after argon laser iridotomy Korean J Ophthalmol 5 1991 37 41
16. Glaucoma Laser Trial Research Group The Glaucoma Laser Trial. I. Acute effects of argon laser trabeculoplasty in intraocular pressure Arch Ophthalmol 107 1989 1135 1142
17. A.L. Robin Medical management of acute postoperative intraocular pressure rises associated with anterior segment ophthalmic laser surgery Int Ophthalmol Clin 30 1990 102 110
18. M.R. Moster, L.W. Schwartz, and G.L. Spaeth Laser iridectomy; a controlled study comparing argon and neodymium:YAG Ophthalmology 93 1986 20 24
19. S. Fourman Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy [letter] Arch Ophthalmol 106 1988 307 308 reply by Robin AL, Pollack IP, de Faller JM, 308-309
20. T.C. Chen, R.T. Ang, and C.L. Grosskreutz Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery Ophthalmology 108 2001 1033 1038
21. R.R. Holweger, and B. Marefat Intraocular pressure change after neodymium:YAG capsulotomy J Cataract Refract Surg 23 1997 115 121
22. A.L. Robin Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty Ophthalmic Surg 22 1991 31 37
23. R.A. Mittra, R.R. Allingham, and M.B. Shields Follow-up of argon laser trabeculoplasty: is a day-one postoperative IOP check necessary? Ophthalmic Surg Lasers 26 1995 410 413
24. A.L. Robin The role of apraclonidine hydrochloride in laser therapy for glaucoma Trans Am Ophthalmol Soc 87 1989 729 761
25. I.P. Pollack, R.H. Brown, and A.S. Crandall Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine Arch Ophthalmol 106 1988 754 757
26. B.S. Rao, and S.S. Badrinath Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery Br J Ophthalmol 73 1989 884 887
27. A.L. Robin, I.P. Pollack, and J.M. deFaller Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy Arch Ophthalmol 105 1987 1208 1211
28. S.D. Barnes, J.A. Campagna, M.S. Dirks, and E.A. Doe Control of intraocular pressure elevations after argon laser trabeculoplasty; comparison of brimonidine 0.2% to apraclonidine 1.0% Ophthalmology 106 1999 2033 2037
29. A.B. Threlkeld, A.A. Assalian, R.R. Allingham, and M.B. Shields Apraclonidine 0.5% versus 1.0% for controlling intraocular pressure elevation after argon laser trabeculoplasty Ophthalmic Surg Lasers 27 1996 657 660
30. L.F. Rosenberg, T. Krupin, and J. Ruderman Apraclonidine and anterior segment laser surgery; comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise Ophthalmology 102 1995 1312 1318
31. J. Ren, D.H. Shin, and H.S. Chung Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty Ophthalmology 106 1999 1135 1139
32. C.E.L. Arieta, M.S. Amaral, and E. Matuda Dorzolamide x apraclonidine in the prevention of the intraocular pressure spike after Nd:YAG laser posterior capsulotomy Curr Eye Res 25 2002 237 241
33. J.R. Nordlund, L.R. Pasquale, and A.L. Robin The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine Arch Ophthalmol 113 1995 77 83
34. J.S. Schuman, B. Horwitz, and N.T. Choplin A 1 year study of brimonidine twice daily in glaucoma and ocular hypertension; a controlled, randomized, multicenter clinical trial Arch Ophthalmol 115 1997 847 852
35. The Brimonidine-ALT Study Group Effect of brimonidine 0.5% on intraocular pressure spikes following 360° argon laser trabeculoplasty Ophthalmic Surg Lasers 26 1995 404 409
36. R. David, G.L. Spaeth, and C.E. Clevenger Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty Arch Ophthalmol 111 1993 1387 1390
37. H.S. Barnebey, A.L. Robin, and T.J. Zimmerman The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty Ophthalmology 100 1993 1083 1088
38. R.J. Derick, A.L. Robin, and T.R. Walters Brimonidine tartrate; a one-month dose response study Ophthalmology 104 1997 131 136